Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic

A Telemedicine Buprenorphine Clinic to Serve New York City

(2021) Babak Tofighi et al.   Journal of Addiction Medicine

Reduction in Oregon's Medication Dosing Visits After the SARS-CoV-2 Relaxation of Restrictions on Take-home Medication

(2021) John W. McIlveen et al.   Journal of Addiction Medicine

COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics

(2021) Lauren Caton et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Trends in Opioid Use Disorder Among Older Adults: Analyzing Medicare Data, 2013–2018

(2021) Carla Shoff et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

Characteristics and correlates of U.S. clinicians prescribing buprenorphine for opioid use disorder treatment using expanded authorities during the COVID-19 pandemic

(2021) Christopher M. Jones et al.   DRUG AND ALCOHOL DEPENDENCE

Do out-of-pocket costs influence retention and adherence to medications for opioid use disorder?

(2021) Christopher Dunphy et al.   DRUG AND ALCOHOL DEPENDENCE

Did drug use increase following COVID-19 relaxation of methadone take-out regulations? 2020 was a complicated year

(2021) Gavin Bart et al.   JOURNAL OF SUBSTANCE ABUSE TREATMENT

The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth

(2021) Richard H. Cales et al.   JOURNAL OF SUBSTANCE ABUSE TREATMENT

Changes in methadone take-home dosing before and after COVID-19

(2021) Ofer Amram et al.   JOURNAL OF SUBSTANCE ABUSE TREATMENT

Addiction Treatment and Telehealth: Review of Efficacy and Provider Insights During the COVID-19 Pandemic

(2021) Tami L. Mark et al.   PSYCHIATRIC SERVICES

An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19

(2020) G. Caleb Alexander et al.   ANNALS OF INTERNAL MEDICINE

Collision of the COVID-19 and Addiction Epidemics

(2020) Nora D. Volkow   ANNALS OF INTERNAL MEDICINE

Drug and Opioid-Involved Overdose Deaths — United States, 2017–2018

(2020) Nana Wilson et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020

(2020) Mark É. Czeisler et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients

(2020) Austin S. Kilaru et al.   JAMA Network Open

Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States

(2020) William C. Goedel et al.   JAMA Network Open

Retention Strategies for Medications for Opioid Use Disorder in Adults

(2020) Brian Chan et al.   Journal of Addiction Medicine

The Impact of COVID-19 on Service Provision for Emergency Department Patients Post-Opioid Overdose

(2020) Alexandra B. Collins et al.   Journal of Addiction Medicine

Continuing increased access to buprenorphine in the United States via telemedicine after COVID-19

(2020) Corey S. Davis et al.   INTERNATIONAL JOURNAL OF DRUG POLICY

Development of a Cascade of Care for responding to the opioid epidemic

(2019) Arthur Robin Williams et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

App Aids Treatment Retention for Opioid Use Disorder

(2019) Rebecca Voelker   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Buprenorphine Use and Spending for Opioid Use Disorder Treatment: Trends From 2003 to 2015

(2018) Andrew W. Roberts et al.   PSYCHIATRIC SERVICES